T-cell development

60,802views

T-cell development

Noor

Noor

Cholinomimetics: Direct agonists
Plasmodium species (Malaria)
Babesia
Giardia lamblia
Entamoeba histolytica (Amebiasis)
Cryptosporidium
Acanthamoeba
Naegleria fowleri (Primary amebic meningoencephalitis)
Toxoplasma gondii (Toxoplasmosis)
Trypanosoma brucei
Trypanosoma cruzi (Chagas disease)
Trichomonas vaginalis
Leishmania
Loa loa (Eye worm)
Toxocara canis (Visceral larva migrans)
Onchocerca volvulus (River blindness)
Ascaris lumbricoides
Anisakis
Angiostrongylus (Eosinophilic meningitis)
Ancylostoma duodenale and Necator americanus
Strongyloides stercoralis
Guinea worm (Dracunculiasis)
Wuchereria bancrofti (Lymphatic filariasis)
Trichinella spiralis
Enterobius vermicularis (Pinworm)
Trichuris trichiura (Whipworm)
Echinococcus granulosus (Hydatid disease)
Diphyllobothrium latum
Paragonimus westermani
Clonorchis sinensis
Schistosomes
Pediculus humanus and Phthirus pubis (Lice)
Sarcoptes scabiei (Scabies)
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Blastomycosis
Pneumocystis jirovecii (Pneumocystis pneumonia)
Candida
Mucormycosis
Aspergillus fumigatus
Sporothrix schenckii
Cryptococcus neoformans
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Viral structure and functions
Varicella zoster virus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Parvovirus B19
Human papillomavirus
Poxvirus (Smallpox and Molluscum contagiosum)
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Poliovirus
Coxsackievirus
Rhinovirus
Hepatitis A and Hepatitis E virus
Hepatitis D virus
Influenza virus
Mumps virus
Measles virus
Respiratory syncytial virus
Human parainfluenza viruses
Dengue virus
Yellow fever virus
Zika virus
Hepatitis C virus
West Nile virus
Norovirus
Rotavirus
Coronaviruses
HIV (AIDS)
Human T-lymphotropic virus
Ebola virus
Rabies virus
Rubella virus
Eastern and Western equine encephalitis virus
Lymphocytic choriomeningitis virus
Hantavirus
Prions (Spongiform encephalopathy)
Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus viridans
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Streptococcus agalactiae (Group B Strep)
Enterococcus
Clostridium perfringens
Clostridium botulinum (Botulism)
Clostridium difficile (Pseudomembranous colitis)
Clostridium tetani (Tetanus)
Bacillus cereus (Food poisoning)
Listeria monocytogenes
Corynebacterium diphtheriae (Diphtheria)
Bacillus anthracis (Anthrax)
Nocardia
Actinomyces israelii
Escherichia coli
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Pseudomonas aeruginosa
Enterobacter
Klebsiella pneumoniae
Shigella
Proteus mirabilis
Yersinia enterocolitica
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Serratia marcescens
Bacteroides fragilis
Yersinia pestis (Plague)
Vibrio cholerae (Cholera)
Helicobacter pylori
Campylobacter jejuni
Neisseria meningitidis
Neisseria gonorrhoeae
Moraxella catarrhalis
Francisella tularensis (Tularemia)
Bordetella pertussis (Whooping cough)
Brucella
Haemophilus influenzae
Haemophilus ducreyi (Chancroid)
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium leprae
Mycobacterium avium complex (NORD)
Mycoplasma pneumoniae
Chlamydia pneumoniae
Chlamydia trachomatis
Borrelia burgdorferi (Lyme disease)
Borrelia species (Relapsing fever)
Leptospira
Treponema pallidum (Syphilis)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Gardnerella vaginalis (Bacterial vaginosis)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Hemolytic disease of the newborn
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Fanconi anemia
Megaloblastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Acute intermittent porphyria
Porphyria cutanea tarda
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Leukemoid reaction
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Langerhans cell histiocytosis
Mastocytosis (NORD)
Multiple myeloma
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinemia
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Free radicals and cellular injury
Necrosis and apoptosis
Ischemia
Hypoxia
Amyloidosis
Inflammation
Wound healing
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Oncogenes and tumor suppressor genes
Choanal atresia
Laryngomalacia
Allergic rhinitis
Nasal polyps
Upper respiratory tract infection
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Nasopharyngeal carcinoma
Tracheoesophageal fistula
Congenital pulmonary airway malformation
Pulmonary hypoplasia
Neonatal respiratory distress syndrome
Transient tachypnea of the newborn
Meconium aspiration syndrome
Apnea of prematurity
Sudden infant death syndrome
Acute respiratory distress syndrome
Decompression sickness
Cyanide poisoning
Methemoglobinemia
Emphysema
Chronic bronchitis
Asthma
Cystic fibrosis
Bronchiectasis
Alpha 1-antitrypsin deficiency
Restrictive lung diseases
Sarcoidosis
Idiopathic pulmonary fibrosis
Pneumonia
Croup
Bacterial tracheitis
Lung cancer
Pancoast tumor
Superior vena cava syndrome
Pneumothorax
Pleural effusion
Mesothelioma
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review

Transcript

Watch video only

Your immune system is like the military - with two main branches, the innate immune response and the adaptive immune response. The innate immune response is immediate and non-specific, meaning that although it can distinguish an invader from a human cell, it doesn’t distinguish one invader from another invader. In contrast, the adaptive immune response is highly specific for each invader, and that’s because the cells of the adaptive immune response have receptors that differentiate one pathogen from another by their unique parts - called antigens. This adaptive immune response takes days to weeks to become activated, during which time the innate immune system provides protection. The second important feature of the adaptive immune response is that it has memory, which means that once a response against an antigen is triggered, subsequent responses will be faster and stronger. This, of course, is why vaccines are so effective – once you get a vaccine containing a part of a pathogen, the next time you see that same pathogen, you will remember the previous encounter (from the vaccine) and you will kill it.

Now, the key cells of the adaptive immune response are the lymphocytes - the B and T cells - which are generated during lymphopoiesis. Lymphopoiesis has two main goals - to generate a diverse set of lymphocytes, each with a unique antigen receptor, and to get rid of lymphocytes that have receptors that are self-reactive, meaning that they could attack one’s own healthy tissue. Normally, hematopoietic stem cells within the bone marrow mature into a common lymphoid progenitor cell, which then becomes either a B-cell or a T cell. To become a B cell, it has to develop into an immature B-cell in the bone marrow and then complete its maturation in the spleen. To become a T cell, it has to migrate to the thymus and become a thymocyte, where it completes its development into a mature T cell. So, “B” for bone marrow and “T” for thymus.

In T cell development, the common lymphoid progenitor leaves the bone marrow and goes to the thymus, because that’s where the developing T cells or thymocytes mature. The thymus is a fatty organ that sits in front of the heart, and as we age, much like our waistlines, the thymus get fattier and fattier. This fat crowds out the space that used to be reserved for T cell development, and it’s one reason why cell mediated immunity declines over time - a process called involution of the thymus. So the thymus has an outer cortex, and an inner medulla. Within the medulla, there are epithelial cells as well as dendritic cells. Both thymic epithelial cells and dendritic cells present antigens to developing T cells on molecules called major histocompatibility complexes or MHC molecules. Thymic epithelial cells will also support the developing T cells. Now, antigen presentation is important because T cells have T cell receptors that can only bind peptide antigens if they’re displayed on an MHC molecule - which is sort of like a silver platter. So if the T cell receptor can’t bind to the MHC molecule, then the T cell isn’t going to able to do its job.

So of course, a key element of T cell development is formation of this T cell receptor, which is made of two chains, an alpha chain which is like the light chain of a B cell receptor, and a beta chain which is like the heavy chain of a B cell receptor. The alpha and beta chains are made up of gene segments called V for variable, D for diversity, and J for joining. The beta chain includes 1 V segment, 1 D segment, and 1 J segment; while the alpha chain only contains 1 V segment and 1 J segment. Every person inherits multiple copies of the V, D, and J segments, and they can be rearranged interchangeably to make a unique structure. This is kind of like how you might have several pairs of shoes, pants, and shirts and can mix and match them to create lots of different outfits. For the alpha chain, each person has between 70-80 variable (or V) gene segments and 61 joining J (or J) segments, and that’s just for the alpha chain! There are more V, D, and J segments for the beta chain. So one T cell might have a beta chain on its T cell receptor that has a V1-D3-J5 combination and an alpha chain that is V7-J2, and another T cell might have a beta chain that has a V44-D10-J1 combination and an alpha chain that is V2-J3, thus making completely different T cell receptors with completely different antigen specificities.

Now, to have a fully functioning T cell receptor, a T cell has to get through a series of successful gene rearrangements, first for the beta chain and then the alpha chain. And if the T cell fails at any stage, it dies! This is a quality control mechanism that ensures that only T cells that express working, or functional, antigen receptors will make it through the gauntlet of maturation.

T cell development is broken into three key stages based on which key molecules it is expressing on its surface at any given time. These molecules, CD3, CD4, and CD8 are expressed in addition to the T cell receptor. All T cells express the CD3 molecule, which is part of the T cell receptor, and once the T cell is fully mature it will either express CD4 or CD8. When the common lymphoid progenitor first arrives in the thymus, it doesn’t express anything on its surface, so it’s considered CD3-, CD4-, and CD8- and is referred to as a double negative stage or DN stage cell because it has neither CD4 nor CD8 at this point. The DN stage can be further broken down into DN1, DN2, DN3, DN4. As the cell moves through the steps to create a functional T cell receptor it will then begin to express CD3 in addition to CD4 and CD8, all on the same cell. The dual expression of CD4 and CD8 is why it’s called the double positive or DP stage. Once the cell completes its expression of a functional T cell receptor it will continue to express CD3 but then it’ll downregulate expression of either CD4 or CD8 and be known as a single positive T cell or SP. Throughout all of these stages, the T cell interacts with epithelial cells of the thymus, which release growth factors as well as molecules like interleukin 7 and 2, called IL-7 and IL-2 for short, and these make the DN1 cells mature. Two enzymes, Rag-1 and Rag-2, start getting expressed, and that signifies that the cell is now a DN2 cell. Now, these two enzymes work together as a multi-subunit enzyme aptly called V(D)J recombinase. To start forming the beta chain, they rearrange together D and J segments on both chromosomes, and the chromosome that successfully rearranges first will then suppress the other chromosome from rearranging - a process called allelic exclusion. This step is important so that each cell expresses only one receptor, which can recognize only one antigen. If a cell successfully joins a D segment to a J segment, then it’s considered a DN3 cell. Now, the DN3 cell has to attach its D-J gene segment to a V gene segment. Once the VDJ segments are combined, the full beta chain’s antigen binding site is complete and gets translated from DNA into messenger RNA. Then, it needs to be recombined with the constant region of the T cell receptor, and eventually this results in a complete receptor protein. At this point, the cell is considered a DN4 cell. Finally, it’s time to test out if the beta chain is functional, by seeing if it can bind to an invariant pre-T alpha chain and get expressed on the cell surface. The invariant pre-T alpha chain is basically something for the beta chain to practice with until the real alpha chain is eventually made.

So the beta chain, the invariant pre-T alpha chain, and CD3 are all expressed on the surface together. The TCR complex sends a signal down the cytoplasmic tails of the receptors to the cell’s nucleus. When the signal is sensed within the cell, the cell starts to divide, and the daughter cells of the rapidly proliferating DN4 cells are called DP cells, because they begin to express both CD4 and CD8 on their surface.

Key Takeaways

T cells, also known as T lymphocytes are a type of lymphocyte that play a central role in cell-mediated immunity. The process of T-cell development begins with the migration of immature T-cell precursors from the bone marrow to the thymus gland, where they undergo a series of steps to become fully mature T-cells. In the thymus, T-cells are exposed to a diverse array of self-antigens and undergo positive and negative selection to ensure that only T-cells that recognize foreign antigens but not self-antigens are allowed to leave the thymus and enter the bloodstream.

During positive selection, T-cells that recognize self-antigens displayed by thymic stromal cells receive survival signals, allowing them to continue their development. During negative selection, T-cells that recognize self-antigens too strongly undergo apoptosis to prevent the development of autoimmunity. Once T-cells have successfully completed positive and negative selection, they leave the thymus and enter the bloodstream, where they travel to various organs and tissues to carry out their functions.